-
Mashup Score: 3What's Next in STAT's Biotech Coverage - 2 month(s) ago
STAT Business Look Ahead is back for 2024: Angus Macaulay is joined by Adam Feuerstein, Jason Ukman, and Brittany Whitmore for a behind the scenes commentary on what’s next for STAT’s biotech coverage. In this live session, they will walk through: – What makes STAT’s biotech coverage a must read and examples of recent standout stories – Adam’s approach to reporting, what he looks for in a story, and the latest project he’s working on – A preview of 2024 brand partnership opportunities that can help brand’s gain an edge
Source: events.bizzabo.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4What's Next in STAT's Biotech Coverage - 2 month(s) ago
STAT Business Look Ahead is back for 2024: Angus Macaulay is joined by Adam Feuerstein, Jason Ukman, and Brittany Whitmore for a behind the scenes commentary on what’s next for STAT’s biotech coverage. In this live session, they will walk through: – What makes STAT’s biotech coverage a must read and examples of recent standout stories – Adam’s approach to reporting, what he looks for in a story, and the latest project he’s working on – A preview of 2024 brand partnership opportunities that can help brand’s gain an edge
Source: events.bizzabo.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4What's Next in STAT's Biotech Coverage - 2 month(s) ago
STAT Business Look Ahead is back for 2024: Angus Macaulay is joined by Adam Feuerstein, Jason Ukman, and Brittany Whitmore for a behind the scenes commentary on what’s next for STAT’s biotech coverage. In this live session, they will walk through: – What makes STAT’s biotech coverage a must read and examples of recent standout stories – Adam’s approach to reporting, what he looks for in a story, and the latest project he’s working on – A preview of 2024 brand partnership opportunities that can help brand’s gain an edge
Source: events.bizzabo.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3What's Next in STAT's Biotech Coverage - 2 month(s) ago
STAT Business Look Ahead is back for 2024: Angus Macaulay is joined by Adam Feuerstein, Jason Ukman, and Brittany Whitmore for a behind the scenes commentary on what’s next for STAT’s biotech coverage. In this live session, they will walk through: – What makes STAT’s biotech coverage a must read and examples of recent standout stories – Adam’s approach to reporting, what he looks for in a story, and the latest project he’s working on – A preview of 2024 brand partnership opportunities that can help brand’s gain an edge
Source: events.bizzabo.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Regulating AI in Digital Mental Health Forum - 2 month(s) ago
The use of AI-enabled technologies for supporting mental health offers great promise, such as by potentially improving treatment outcomes as well as crisis and addiction support, suicide prevention, and building mental resilience and wellbeing. Regulating the safe use of AI in mental health is an urgent priority and calls for many actions including robust clinical and data governance frameworks. When working with AI-enabled technologies in mental health spaces it is crucial that risks and harms are minimized to avoid potentially life-altering and life-threatening outcomes. In this workshop, we will address key questions related to safety and regulation of AI in mental health. For example, to what extent are AI-enabled technologies embracing clinical governance and what do ‘good practices’ and ‘gold standards’ currently look like in this highly sensitive area? What are the growing efforts to digitize public mental health services using AI-enabled technologies? Are existing regulatory
Source: events.bizzabo.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Glaucoma 360 New Horizons Forum - 4 month(s) ago
Now in its 13th year, the Glaucoma 360 New Horizons Forum unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment. Presented by the Glaucoma Research Foundation, this annual catalyst meeting is designed to bring the essential components together in order to speed the translation of new ideas into clinical practice. New Horizons Forum is the centerpiece of Glaucoma 360, a series of three events uniting research, industry, and philanthropy to cure glaucoma and restore vision. Please note that each event requires separate registration. This event will be in-person only.
Source: events.bizzabo.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1Glaucoma 360 New Horizons Forum - 4 month(s) ago
Now in its 13th year, the Glaucoma 360 New Horizons Forum unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment. Presented by the Glaucoma Research Foundation, this annual catalyst meeting is designed to bring the essential components together in order to speed the translation of new ideas into clinical practice. New Horizons Forum is the centerpiece of Glaucoma 360, a series of three events uniting research, industry, and philanthropy to cure glaucoma and restore vision. Please note that each event requires separate registration. This event will be in-person only.
Source: events.bizzabo.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1Improve the clinician’s understanding of soft tissue sarcoma subtypes: special focus on dedifferentiated liposarcoma - 5 month(s) ago
Join us for this CME-accredited webinar. Our key opinion leaders will focus their talks on: • the latest findings related to subtype specific clinical, histopathological, and genomic characteristics of liposarcoma • the latest guidelines on clinical characteristics, imaging, karyotypes, genomic profiles, and histological variations • different approaches taken, potential diagnostic misinterpretations, and guidelines to troubleshoot when there are concerns. This Ask-the-Expert webinar is designed for health care professionals (surgical, orthopedic, and radiation oncologists, as well as connective tissue pathologists and radiologists and other members of the MDT) who are interested in learning more on the latest research, treatment, and clinical management of patients with dedifferentiated liposarcoma. There will be the opportunity to ask questions directly to the speakers during the live Q&A or you can send your questions prior to the event. So, register today to submit your questions!
Source: events.bizzabo.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Improve the clinician’s understanding of soft tissue sarcoma subtypes: special focus on dedifferentiated liposarcoma - 5 month(s) ago
Join us for this CME-accredited webinar. Our key opinion leaders will focus their talks on: • the latest findings related to subtype specific clinical, histopathological, and genomic characteristics of liposarcoma • the latest guidelines on clinical characteristics, imaging, karyotypes, genomic profiles, and histological variations • different approaches taken, potential diagnostic misinterpretations, and guidelines to troubleshoot when there are concerns. This Ask-the-Expert webinar is designed for health care professionals (surgical, orthopedic, and radiation oncologists, as well as connective tissue pathologists and radiologists and other members of the MDT) who are interested in learning more on the latest research, treatment, and clinical management of patients with dedifferentiated liposarcoma. There will be the opportunity to ask questions directly to the speakers during the live Q&A or you can send your questions prior to the event. So, register today to submit your questions!
Source: events.bizzabo.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11The Evolving Therapeutic Landscape of Gastric Cancer - 5 month(s) ago
Join us for this CME-accredited webinar, The talks will focus on: • the latest guideline recommendations and best-practice algorithms to devise precision treatment strategies for patients • the importance of the multidisciplinary team in treatment selection with a focus on surgical decision making, surgical approaches, neoadjuvant and adjuvant therapy • ongoing clinical trials and the latest FDA-approved treatments to clearly understand the safety/efficacy profile of novel agents, especially in how to deal with adverse effects (such as toxicities) This Ask-the-Expert webinar is designed for health care professionals (gastrointestinal medical and surgical oncologists and other members of the MDT,) who are interested in learning more on the latest research, treatment, and clinical management of patients with advanced gastric and esophageal cancers. There will be the opportunity to ask questions directly to the speaker during the live Q&A or you can send your questions prior to the event.
Source: events.bizzabo.comCategories: General Medicine News, Onc News and JournalsTweet-
Join us for a free CME-accredited webinar on the latest advancements in the treatment of advanced #GastricCancer and #EsophagealCancer! Don't miss this opportunity to engage w/ experts in the field. Register here: https://t.co/vJMkF3Nrcc @KelseyLauMin @iGUT_Houston @OncoAlert https://t.co/knYbUVfFEi
-
Today at 1 PM ET: Get a behind the scenes look at what’s next for STAT’s biotech coverage at our Business Look Ahead virtual event. https://t.co/u6xO5MqB57 https://t.co/14OZJJeh8u